Literature DB >> 33059953

Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression.

Wenjie Yang1, Ke Wang2, Jianbin Ma1, Ke Hui1, Wei Lv1, Zhenkun Ma2, Mengxi Huan1, Lin Luo3, Xinyang Wang2, Lei Li4, Yule Chen5.   

Abstract

BACKGROUND: Recent studies indicate that androgen deprivation therapy (ADT), the main therapeutic approach for metastatic prostate cancer (PCa), accelerates PCa invasion and metastasis. Annexin A1 (ANXA1) is a Ca2+-regulated phospholipid-binding protein that can promote PCa migration and invasion. AIM OF THE STUDY: The aim of this study is to determine whether ANXA1 is regulated by ADT and participates in PCa progression after ADT, and to explore the possible mechanism of ANXA1-mediated PCa migration.
METHODS: Expression of ANXA1 and androgen receptor (AR) in PCa cell lines and tissues was detected, and the association between these two proteins were analyzed. Expression of ANXA1 was evaluated after AR knockdown or AR inhibition in PCa cell lines. Cell migration of PCa cell liness after ANXA1 knockdown or overexpression was determined by in vitro migration assay. Transcriptome analysis was used to explore the possible mechanism of ANXA1-mediated PCa migration.
RESULTS: ANXA1 expression in PCa cell lines and tissues was reversely associated with AR. In vitro studies revealed an increase in ANXA1 expression after AR knockdown or treatment with AR antagonist. Moreover, functional assays indicated that ANXA1 knockdown in PCa cells significantly inhibited cell migration, while ANXA1 overexpression in PCa cells significantly accelerated cell migration. Transcriptome analysis showed that ANXA1 regulated multiple genes involved in cell junction organization, such as CADM1, LIMCH1 and PPM1F.
CONCLUSIONS: Our results indicate that ADT might accelerate PCa metastasis via ANXA1 expression and PCa cell migration.
Copyright © 2021 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ANXA1; Androgen receptor; Metastasis; Migration; Prostate cancer

Mesh:

Substances:

Year:  2020        PMID: 33059953     DOI: 10.1016/j.arcmed.2020.10.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

Review 1.  Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer.

Authors:  Madhuvanthi Giridharan; Vasu Rupani; Satarupa Banerjee
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-30

Review 2.  Targeting the Hippo Pathway in Prostate Cancer: What's New?

Authors:  Kelly Coffey
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.575

3.  Construction of Potential Gene Expression and Regulation Networks in Prostate Cancer Using Bioinformatics Tools.

Authors:  Heyu Liu; Lirong Li; Yuan Fan; Yaping Lu; Changhong Zhu; Wei Xia
Journal:  Oxid Med Cell Longev       Date:  2021-08-31       Impact factor: 6.543

4.  In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer.

Authors:  Soulaimane Aboulouard; Maxence Wisztorski; Marie Duhamel; Philippe Saudemont; Tristan Cardon; Fabrice Narducci; Anne-Sophie Lemaire; Firas Kobeissy; Eric Leblanc; Isabelle Fournier; Michel Salzet
Journal:  Cell Rep Med       Date:  2021-06-15

5.  miR221 regulates cell migration by targeting annexin a1 expression in human mesothelial MeT-5A cells neoplastic-like transformed by multi-walled carbon nanotube.

Authors:  Li Ju; Lijin Zhu; Hao Wu; Min Yu; Xianhong Yin; Zhenyu Jia; Lingfang Feng; Shibo Ying; Hailing Xia; Shuzhi Zhang; Jianlin Lou; Jun Yang
Journal:  Genes Environ       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.